Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of non-culprit lesions in STEMI patients. 

Sub-estudio del Compare-Acute: Historia natural de las lesiones no culpables del infarto

We analyzed data of all Compare-Acute patients (Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD) after PCI, from lesions assessed with FFR and treated medically.  The treating cardiologists were blind to FFR values. 

Primary end point was a The primary endpoint was the composite of cardiovascular mortality, target vessel-related (non-IRA with FFR measurement at primary percutaneous coronary intervention) nonfatal MI, and target vessel revascularization: major adverse cardiac events at 24 months. 

It included 751 patients (963 vessels). Non-culprit lesions that were not revascularized showed significantly lower FFR (0.78 vs. 0.84; p<0.001). 

This difference was significative in all vessels.


Read also: Bleeding and Cardiogenic Shock: An “Unholy Alliance”?


Mean FFR of original non- culprit lesions that later presented as MI also resulted lower (0.79 vs. 0.84; p=0.016).

All data point to a significantly higher events rate (p<0.001) in the lowest tertile of FFR (<0.80) compared against the two higher tertiles (0.80 to 0.87 and >0.88).

This phenomenon has been seen in previous studies. We should get rid of this idea of FFR provides a binary cutoff value around 0.8 and rather understand these results as a continuum of variables.  


Read also: COMPARE-ACUTE: FFR-Guided Non-Culprit Vessel Revascularization in Primary Angioplasty.


In any given lesion, the closer to 0.8, the higher the chances of these lesions evolving with events. This increase in bad odds is not linear, but rather shoots up disproportionally the closer we get to 0.8.

Conclusion

In patients with ST elevation MI and multivessel disease undergoing medical treatment in non-culprit lesions after successful primary PCI, there is a non-linear and inverse correlation between FFR values in non-culprit lesions and events. 

It is important to highlight there is worse prognosis around the 0.8 cutoff value.

Original Title: The Natural History of Nonculprit Lesions in STEMI. An FFR Substudy of the Compare-Acute Trial.

Reference: Zsolt Piróth et al. J Am Coll Cardiol Intv 2020;13:954–61.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...